Clinical Trial Update: A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients [Phase 4]

View source ↗

Summary

Phase 4 study investigating the relationship between anti-laronidase antibodies and urinary glycosaminoglycans in Aldurazyme-treated patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hurler Syndrome
• Hurler-scheie Syndrome
• Mucopolysaccharidosis Type
• Scheie Syndrome

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Mucopolysaccharidosis I, Hurler's Syndrome | Phase 4 | Status: COMPLETED